Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
about
An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2.From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.Managing drug resistance in cancer: lessons from HIV therapy
P2860
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@en
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@nl
type
label
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@en
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@nl
prefLabel
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@en
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@nl
P2860
P356
P1433
P1476
Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
@en
P2860
P304
P356
10.1159/000332000
P577
2012-01-24T00:00:00Z